DOI QR코드

DOI QR Code

Availability of CLSI method and MicroScan MICroSTREP plus panel for Antimicrobial Susceptibility Testing of α-hemolytic streptococci Isolated from Patients

환자(患者)에서 분리한 연쇄상구균(連鎖狀球菌)에 대한 CLSI방법(方法)과 MicroScan MICroSTREP plus panel의 항균제(抗菌劑) 감수성(感受性) 검사(檢査)의 유용성(有用性) 고찰(考察)

  • Kim, Sang-Ha (Department of Public Health and Welfare Graduate school of Konyang University) ;
  • Kim, Sang-Ha (Department of Laboratory Medicine of Sangju Hospital, The Republic of National Red Cross) ;
  • Kim, Young-Kwon (Department of Biomedical Laboratory Science of Konyang University)
  • 김상하 (건양대학교병원 진단검사의학과) ;
  • 김상하 (대한적십자사상주병원 진단검사의학과) ;
  • 김영권 (건양대학교 임상병리학과)
  • Received : 2011.08.23
  • Accepted : 2011.11.10
  • Published : 2011.11.30

Abstract

The purpose of this study was availability for the classical test method. The test were called CLSI(Clinical and Laboratory Standards Institute) that was disk diffusion method, the newly designed E-test(made use disk diffusion method) can estimate the MIC and modified broth microdilution method that was standardized. Those tests were observed by MicroScan MicroSTREP plus panel. Target strains were 53 strains of S.pneumoniae and 51 strains of ${\alpha}$-hemolytic streptococci which were separated from the inpatient in university hospital for 6 months from February to August, 2009. The 9 antimicrobial agent of target evaluation were cefotaxime, chloramphenicol, clindamycin, erythromycin, levofloxacin, penicillin, tetracycline, trimethoprim/sulfamethoxazole, and vancomycin. researched comparative analysis both S.pneumoniae and ${\alpha}$-hemolytic streptococci. The result of the high concordance rates in ${\alpha}$-hemolytic streptococci was recognized formally in clinical microbiology laboratory.

본 연구에서는 전 세계적으로 표준화된 전통적 항균제 감수성 검사방법인 CLSI(C linical and Laboratory Standards Institute)디스크 확산법과 디스크 확산법을 이용 해 MIC를 측정할 수 있도록 새롭게 고안된 E-test 방법과 최근 도입된 미량 액체 배지 희석법을 이용한 항균제 감수성 검사 자동화 장비인 MicroScan MICroSTR EP plus panel를 이용한 MIC 측정방법들의 일치도를 비교하여 MicroScan MICroS TREP plus panel 검사방법의 유용성을 관찰하고자 하였다. 대상균주는 2009년 2월부터 8월까지 6개월 동안 대전의 한 대학병원 임상환자에서 분리된 폐렴사슬알균 53균주와 알파용혈 사슬알균 51균주를 대상으로 하였으며 항 균제는 cefotaxime, chloramphenicol, clindamycin, erythromycin, levofloxacin, penicillin, tetracycline, trimethoprim/sulfamethoxazole, vancomycin 등 9가지 항균제를 평가 대상으로 하였다. 폐렴사슬알균 뿐만 아니라 알파용혈 사슬균에 대해서도 비교분석을 하였고 그 결과 알파용혈 사슬균에 대해 높은 일치율이 관찰되어 임상미생물 검사실에서 신속 정확한 최소발율 억제농도를 측정하는데 많은 도움이 되리라 생각된다.

Keywords

References

  1. Spellerberg B and Brandt C. Streptococcus. In: Murray PR, Baron EJ, et aleds. Manual of clinical microbiology. 9th ed. Washington DC: ASM press, 2007:412-25.
  2. Jorgensen JH, McElmeel ML, Crawford SA. Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Strep tococcus pneumoniae challenge strains and recent clinical isolates. J Clin Microbiol 1998;36:788-91.
  3. Reichler, M. R., A. A. Allphin, R. F. Breiman, J.R. Schreiber, J. E. Arnold, L. K. McDougal, R. R. Facklam, B. Boxerbaum, D. May, R. O. Walton, and M R. Jacobs. 1992. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J. Infect. Dis. 166:1346-1353 https://doi.org/10.1093/infdis/166.6.1346
  4. Kim KH, Sohn YM, Kang JH, Kim KN, Kim DS, Kim JH, et al. The causa tive organisms of bacterial meningitis in Korean children, 1986-1995. J Kore an Med Sci 1998;13: 60-4. https://doi.org/10.3346/jkms.1998.13.1.60
  5. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995; 274:1706-13. https://doi.org/10.1001/jama.1995.03530210060032
  6. Ruoff KL, Whiley RA, Beighton D.Streptococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiol ogy.7th ed.Washington DC: American Society for Microbiology, 1999: 283-96.
  7. Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am JMed 1994;97:256-64.
  8. Heo JW, Na J, LEE SH, bae JH, Streptococcus pneumoniae penicillin and cefotaxim susceptibility of E-test the usefulness of a search Corporation. Journal of Clinical Pathology 1996; 16:33 0-9.
  9. Lalitha MK, Manayani DJ, Priya L, Jesu dason MV, Thomas K, Steinhoff MC. E test as an alternative to conventional MIC determination for surveillance of drug resistant Streptococcus pneumoniae. Indian JMed Res1997;10 6:500-3.
  10. Shin JH, Jung HJ, Kim HR, Jeong J, Jeong SH, Kim S, Lee EY, Lee JN,Ch ang CL. Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoni ae at five tertiary-care hospitals in Korea. Antimicrob Agents Chemother 51:2625-7, 2007 https://doi.org/10.1128/AAC.00107-07
  11. Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial. Therapy. DOI : 10.3947/ic. 2009.41.3.133
  12. Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, et al. Epidemiolgy and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surve illance of resistant pathogens. International Journal of Antimicrobial Agents 2008;31:107-14. https://doi.org/10.1016/j.ijantimicag.2007.09.014
  13. Diekema DJ, Beach ML, Pfaller MA, Jones RN; SENTRYP articipants Group. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin Amer ica. Clin Microbiol Infect 2001;7:152-7. https://doi.org/10.1046/j.1198-743x.2001.00230.x
  14. LEE HD, Yong DE, LE KW, Hong SG, KIM UJ, Jeong SH. 2004, 12 hospitals in Korea sep arated from the main bacterial antibiotic naese ongryul. Journal of Clinical Microbiology 2005;8:66-73).
  15. Musher DM. Infections caused by Streptococcus pneumoniae :clinical spectrum, pathogenesis, immunity and treatment. Clin Infect Dis 1992, 14:801-7. https://doi.org/10.1093/clinids/14.4.801
  16. Clinical and Laboratory Standards Institute. Performance standards for anti microbial susceptibility testing. Eighteenth informational supplement, M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
  17. Kim HS, Kim JS, Ha CK, Song W, Lee KM. Evaluation of MicroScanMICro STREP Plus Antimicrobial susceptibility panel for testing Streptococcus pneumoniae. Korean J Clin Microbiol 2008;11:18-22. https://doi.org/10.5145/KJCM.2008.11.1.18
  18. Woo HY, Nam MH, LEE NY: Streptococcus pn eumoniae antimicrobial susceptibility testing of the VITEK-2 System for the assessment. Journ al of Clinical Pathology 2001; 21: 129-34
  19. Antimicrobial susceptibility testing of fungal pn eumonia known for evaluation of the Phoenix System. Department of Laboratory Medicine 20 09 :29:212-7.
  20. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev1990;3:171-96. https://doi.org/10.1128/CMR.3.2.171
  21. LEE SH, KIM YS, Woo JH, Ryu JS, Bae JH, Cephalosporin Resistance 2 cases of meningitis caused by Streptococcus pneumoniae. Journal of Clinical Pathology 1997; 17: 629-35
  22. Lee H, Yong D, Lee K, Hong SG, Kim EC, Jeong SH, et al. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea in 2004. Korean J Clin Microbiol 2005;8:66-73.
  23. SONG JH, Jeong SI, Go GS, KIM NY, SON JS of Asia for some areas of pneumococcal antibio tic resistance patterns, and change status. Soci ety of Infection and Chemotherapy 2004; 48:2101-7.